Lv1
2 积分 2022-12-22 加入
Patent landscape in hydroxamic acid-based HDAC inhibitors (2020–2024): structure–activity relationships and mechanistic insights
1天前
已完结
RNAi-based drug design: considerations and future directions
1个月前
已完结
Mechanism and Molecular Target of Substituted Triazoles: A Therapeutic Strategy in Anticancer Drug Discovery
1个月前
已完结
Kidney immunology from pathophysiology to clinical translation
1个月前
已完结
Design, synthesis, and evaluation of trisubstituted bicyclo[2.2.2]oct-2-enes as non-classical isosteres of trisubstituted benzenes
1个月前
已完结
Preparation of 3,5-Methanobenzo[ b ]azepines: An sp 3 -Rich Quinolone Isostere
1个月前
已完结
Abstract 5791: Preclinical characterization of NEO-811, a novel molecular glue degrader of ARNT for the treatment of clear cell renal cell carcinoma
3个月前
已关闭
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)
4个月前
已完结
Recent developments of monofluorination via three-component reactions
1年前
已完结
Small-molecule PI3Kα binder with selective anticancer activity
1年前
已完结
皖公网安备34019202002308
